Effects of betaine on lipopolysaccharide-induced memory impairment in mice and the involvement of GABA transporter 2

• Published in: Journal of neuroinflammation Vol. 8; no. 1; p. 153
• Main Authors: Miwa, Masaya, Tsuboi, Mizuki, Noguchi, Yumiko, Enokishima, Aoi, Nabeshima, Toshitaka, Hiramatsu, Masayuki
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 04.11.2011; BioMed Central; BMC
• Subjects: Abiotic stress; Animals; Behavior; Betaine - pharmacology; Cytokines - biosynthesis; Experiments; GABA; GABA Plasma Membrane Transport Proteins - metabolism; Genetic aspects; Homocysteine; Inflammation - chemically induced; Laboratory animals; Lipopolysaccharides; Lipopolysaccharides - toxicity; Lipotropic Agents - pharmacology; Male; Maze Learning - drug effects; Memory Disorders - chemically induced; Memory Disorders - metabolism; Mice; Neurodegeneration; Nitric oxide; Oxidative stress; Physiological aspects; Proteins; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger - analysis; Rodents
• ISSN: 1742-2094; 1742-2094
• DOI: 10.1186/1742-2094-8-153

Betaine (glycine betaine or trimethylglycine) plays important roles as an osmolyte and a methyl donor in animals. While betaine is reported to suppress expression of proinflammatory molecules and reduce oxidative stress in aged rat kidney, the effects of betaine on the central nervous system are not well known. In this study, we investigated the effects of betaine on lipopolysaccharide (LPS)-induced memory impairment and on mRNA expression levels of proinflammatory molecules, glial markers, and GABA transporter 2 (GAT2), a betaine/GABA transporter. Mice were continuously treated with betaine for 13 days starting 1 day before they were injected with LPS, or received subacute or acute administration of betaine shortly before or after LPS injection. Then, their memory function was evaluated using Y-maze and novel object recognition tests 7 and 10-12 days after LPS injection (30 μg/mouse, i.c.v.), respectively. In addition, mRNA expression levels in hippocampus were measured by real-time RT-PCR at different time points. Repeated administration of betaine (0.163 mmol/kg, s.c.) prevented LPS-induced memory impairment. GAT2 mRNA levels were significantly increased in hippocampus 24 hr after LPS injection, and administration of betaine blocked this increase. However, betaine did not affect LPS-induced increases in levels of mRNA related to inflammatory responses. Both subacute administration (1 hr before, and 1 and 24 hr after LPS injection) and acute administration (1 hr after LPS injection) of betaine also prevented LPS-induced memory impairment in the Y-maze test. These data suggest that betaine has protective effects against LPS-induced memory impairment and that prevention of LPS-induced changes in GAT2 mRNA expression is crucial to this ameliorating effect.